Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trialMasatoshi Kudo, Yasuaki Arai, Kiwamu Okita et al.|Gut|2019Cited by 732
Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarterial Chemoembolization Alone in Patients with Unresectable Hepatocellular CarcinomaMasatoshi Kudo, Kazuomi Ueshima, Masafumi Ikeda et al.|Liver Cancer|2022Cited by 134
Clinical characteristics and prognostic factors for advanced hepatocellular carcinoma with extrahepatic metastasisHajime Aino, Michio Sata, Shuji Sumie et al.|Molecular and Clinical Oncology|2014Cited by 84
Sorafenib for the treatment of advanced hepatocellular carcinoma with extrahepatic metastasis: a prospective multicenter cohort studyMasahito Nakano, Masatoshi Tanaka, Ryoko Kuromatsu et al.|Cancer Medicine|2015Cited by 65
Serum vascular endothelial growth factor as a predictor of response and survival in patients with advanced hepatocellular carcinoma undergoing hepatic arterial infusion chemotherapyTakashi Niizeki, Michio Sata, Shuji Sumie et al.|Journal of Gastroenterology|2012Cited by 59